Based on data from TCGA, we found that lung cancer patients with high expression of PLK1 exhibited poorer survival (P < 0.05) compared to those with low expression of PLK1 after receiving chemotherapy (Fig. 2A). The gene discussed is PLK1; the disease is lung carcinoma.